HAWAII BIOTECH OPENS NEW STATE-OF-THE-ART R&D LABORATORIES AND HEADQUARTERS - 21 Feb 2017
From the Hawaii Biotech archive: (Honolulu, Feb. 21, 2017) -- Hawaii Biotech, Inc., in the forefront of creating vaccines for established and emerging infectious diseases such as Zika and anti-toxin drugs for weaponized biological threats, has finished constructi
Chikungunya grant award - 30 Aug 2016
From the Hawaii Biotech archive: (HONOLULU, HI, & HOUSTON, TX, Aug. 30, 2016) - The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded Hawaii Biotech, Inc. a Small Business Innovation Research Phase I gra
HTDC SBIR Matching Grants - 26 July 2016
From the Hawaii Biotech archive: DAVID Y. IGE GOVERNOR LUIS P. SALAVERIA DIRECTOR ROBBIE MELTON EXECUTIVE DIRECTOR
Soligenix UH HBI Ebola Results - 12 July 2016
From the Hawaii Biotech archive: Princeton, NJ and Honolulu, HI - July 12, 2016 - Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced tod
Hirono-Ige Zika Emergency Awareness - 2 May 2016
From the Hawaii Biotech archive: FOR IMMEDIATE RELEASE Contact: Dr. Elliot Parks, 808-792-1399 eparks@hibiotech.com
Hawaii Biotech to Relocate to Dole Cannery - 11 Dec 2015
From the Hawaii Biotech archive: (Honolulu, Dec. 11, 2015) -- Hawaii Biotech, Inc., Honolulu's oldest biotech company, has signed a five-year lease with Castle & Cooke for 10,835 square feet of space on the second floor of Dole Cannery. The vaccine and drug resea
HAWAII BIOTECH RECEIVES DENGUE VACCINE CONTRACT - 3 Dec 2015
From the Hawaii Biotech archive: (Honolulu, Dec. 03, 2015) -- Hawaii Biotech, Inc. (HBI), announced today that the US Army SBIR Program awarded the company a Small Business Innovation Research (SBIR) Phase I contract to develop an effective dengue vaccine to prot
Soligenix UH HBI Ebola - 28 May 2015
From the Hawaii Biotech archive: Princeton, NJ - May 28, 2015 - Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodef
HAWAII BIOTECH JOINS FORCES WITH UH ON EBOLA VACCINE - 20 May 2015
From the Hawaii Biotech archive: The Filovirus vaccine was originally developed by Dr. Axel Lehrer and others at HBI while Dr. Lehrer was an employee with the company. Last year, Dr. Lehrer assumed a position with UH Mānoa, which allowed Dr. Lehrer to continue hi
HAWAII BIOTECH MOVES INTO DRUG DISCOVERY - 5 Mar 2014
From the Hawaii Biotech archive: (Honolulu, HI, March 5, 2014) - The Department of Defense, Defense Threat Reduction Agency, has awarded Hawaii Biotech, Inc., a contract to continue developing drugs to block botulinum toxin, the toxin that causes the life-threate
